Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Limited Adipose Tissue Expandability as a Risk Factor for Development of Type 2 Diabetes: the Role of Preadipocytes

NCT03155412 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT03155412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03155412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Limited Adipose Tissue Expandability as a Risk Factor for Development of Type 2 Diabetes: the Role of Preadipocytes
Lead sponsor
Charles University, Czech Republic
Phase
Observational
Overall status
Completed
Start date
January 31, 2016
Completion date
January 31, 2019
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes mellitus